The Role of Active Metabolites in Drug Toxicity

SummaryAdverse drug reactions can be caused by the parent drug or a metabolite of that drug. The metabolite may be stable or chemically reactive, the resultant toxicity being either a direct extension of the pharmacology of the drug, or unrelated to the known pharmacology of the drug and dependent on the chemical properties of the compound. Many different organ systems may be affected, and there are several mechanisms involved in determining organ-specific, and sometimes cell-selective, toxicity. An imbalance between bioactivation of a drug to a toxic metabolite and its detoxification is of prime importance in determining individual susceptibility. Such an imbalance may be genetically determined or acquired and, furthermore, may be systemic or tissue-specific. Prevention of metabolite-mediated toxicity is possible once the mechanism of toxicity has been elucidated.

[1]  J. Gage The action of paraquat and diquat on the respiration of liver cell fractions. , 1968, The Biochemical journal.

[2]  M. Brin,et al.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.

[3]  S. F. Sullivan,et al.  The effect of acidosis on sympatho-adrenal stimulation. Particular reference to cardiopulmonary bypass. , 1966, JAMA.

[4]  S. Spielberg,et al.  In vitro evaluation of a toxic metabolite of sulfadiazine. , 1985, Canadian journal of physiology and pharmacology.

[5]  S. Sternberg,et al.  Cyclophosphamide and urinary bladder toxicity. , 1961, Cancer research.

[6]  Z. Rossetti,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. , 1988, Biochemical pharmacology.

[7]  W. Mccaughey A summary of the National Halothane Study. , 1972, British journal of anaesthesia.

[8]  R. Diasio,et al.  Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora , 1986, Antimicrobial Agents and Chemotherapy.

[9]  D. Morin,et al.  Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. , 1992, The Journal of pharmacology and experimental therapeutics.

[10]  L. Seeff,et al.  Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. , 1986, Annals of internal medicine.

[11]  P. Dayer,et al.  Fetal Drug Metabolism and Its Possible Clinical Implications , 1991, Clinical pharmacokinetics.

[12]  D. Calne,et al.  AETIOLOGY OF PARKINSON'S DISEASE , 1983, The Lancet.

[13]  T. Devereux,et al.  Xenobiotic metabolism by isolated pulmonary cells. , 1989, Pharmacology & therapeutics.

[14]  C. W. Parker Allergic reactions in man. , 1982, Pharmacological reviews.

[15]  N. Kitteringham,et al.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. , 1988, British journal of clinical pharmacology.

[16]  S. Spielberg,et al.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.

[17]  A. Herbst,et al.  Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. , 1987 .

[18]  G. Bryan,et al.  METABOLISM AND DISPOSITION OFN-{4-(5-NITRO-2-FURYL)-[2-14C]THIAZOLYL}ACETAMIDEIN THE RAT , 1975 .

[19]  F. Robicsek Acute methemoglobinemia during cardiopulmonary bypass caused by intravenous nitroglycerin infusion. , 1985, The Journal of thoracic and cardiovascular surgery.

[20]  C. Laskin,et al.  Autoantibodies in alcoholic liver disease. , 1990, The American journal of medicine.

[21]  D. Wortham,et al.  Comparison of the Effect of the Macrolide Antibiotics Erythromycin, Clarithromycin and Azithromycin on Terfenadine Steady-State Pharmacokinetics and Electrocardiographic Parameters , 1994 .

[22]  J. Castro,et al.  Carcinoma of the bladder complicating cyclophosphamide therapy. , 1975, British journal of urology.

[23]  G. Duggin,et al.  Mechanisms in the development of analgesic nephropathy. , 1980, Kidney international.

[24]  P. Cox Cyclophosphamide cystitis--identification of acrolein as the causative agent. , 1979, Biochemical pharmacology.

[25]  T. Kumazawa,et al.  Toxicity following methoxyflurane anaesthesia , 1970, Canadian Anaesthetists' Society journal.

[26]  J. Oates,et al.  Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. , 1978, The New England journal of medicine.

[27]  A. Breckenridge,et al.  The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. , 1992, British journal of clinical pharmacology.

[28]  T. Vree,et al.  Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis. , 1996, The Journal of antimicrobial chemotherapy.

[29]  J. Timbrell Principles of biochemical toxicology , 1991 .

[30]  J. Halperin,et al.  Neuroactive kynurenines in Lyme borreliasis , 1992, Neurology.

[31]  R. Pounder,et al.  Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. , 1975, Gut.

[32]  B McNutt,et al.  Torsades de pointes occurring in association with terfenadine use. , 1991, JAMA.

[33]  J. Jimenez,et al.  DNA damage in intact cells induced by bacterial metabolites of chloramphenicol , 1988, American journal of hematology.

[34]  N. T. Smith,et al.  Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. , 1977, Anesthesiology.

[35]  G. Barr,et al.  Renal Effects and Metabolism of Isoflurane in Man , 1974, Anesthesiology.

[36]  W. Seinen,et al.  Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals , 1989 .

[37]  T. Stillwell,et al.  Cyclophosphamide‐induced hemorrhagic cystitis: A review of 100 patients , 1988, Cancer.

[38]  D. V. Von Hoff,et al.  Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. , 1977, The American journal of medicine.

[39]  R. Finnell,et al.  Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. , 1992, Neurology.

[40]  J. Shelley Pharmacological mechanisms of analgesic nephropathy. , 1978, Kidney international.

[41]  A. S. Gross,et al.  The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects. , 1990, Pharmacology & therapeutics.

[42]  Wolf Cr Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals. , 1991 .

[43]  F. Freiha,et al.  Hemorrhagic cystitis: a review. , 1990, The Journal of urology.

[44]  R. Woosley,et al.  Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin , 1992, Clinical pharmacology and therapeutics.

[45]  R. V. van Oers,et al.  Effects of recombinant human granulocyte colony‐stimulating factor on leucopenia in zidovudine‐treated patients with AIDS and AIDS related complex, a phase I/II study , 1991, British journal of haematology.

[46]  P. Killenberg,et al.  Acetaminophen hepatotoxicity. An alternative mechanism. , 1983, Biochemical pharmacology.

[47]  A. Yunis,et al.  Chloramphenicol: relation of structure to activity and toxicity. , 1988, Annual review of pharmacology and toxicology.

[48]  J. Langston,et al.  Aetiology of Parkinsońs disease , 1983 .

[49]  N. Kitteringham,et al.  Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro. , 1989, British journal of clinical pharmacology.

[50]  E. Kharasch,et al.  Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and Methoxyflurane , 1993, Anesthesiology.

[51]  K Farrell,et al.  Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[52]  M. Murray,et al.  Renal toxicity of the nonsteroidal anti-inflammatory drugs. , 1993, Annual review of pharmacology and toxicology.

[53]  H. Satoh,et al.  The immunologic and metabolic basis of drug hypersensitivities. , 1988, Annual review of pharmacology and toxicology.

[54]  S. Wallace,et al.  Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.

[55]  H. Zimmerman,et al.  Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .

[56]  M. Pirmohamed,et al.  Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine. , 1991, British journal of clinical pharmacology.

[57]  B. Burchell,et al.  UDP-glucuronosyltransferases: a family of detoxifying enzymes. , 1990, Trends in pharmacological sciences.

[58]  D. Nebert,et al.  Genes for cytochrome P-450 and their regulation. , 1986, CRC critical reviews in biochemistry.

[59]  M. Pirmohamed,et al.  Idiosyncratic reactions to antidepressants: a review of the possible mechanisms and predisposing factors. , 1992, Pharmacology & therapeutics.

[60]  R. Morrison,et al.  Renal failure following methoxyflurane analgesia. , 1987, The New Zealand medical journal.

[61]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Hammer,et al.  Zidovudine: Five Years Later , 1992, Annals of Internal Medicine.

[63]  J. Sommadossi,et al.  Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. , 1989, Molecular pharmacology.

[64]  R. Birge,et al.  Selective protein arylation by acetaminophen and 2,6-dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice. Relationship to cytotoxicity. , 1989, Biochemical pharmacology.

[65]  A. Stanners,et al.  Torsades de pointes complicating treatment with terfenadine. , 1991, BMJ.

[66]  O. Niemelä,et al.  Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. , 1991, The Journal of clinical investigation.

[67]  M. Yaqoob,et al.  Renal impairment with chronic hydrocarbon exposure. , 1993, The Quarterly journal of medicine.

[68]  W. Hofmann,et al.  Fatal Liver Failure in 16 Children with Valproate Therapy , 1988, Epilepsia.

[69]  T. Kelly Teratogenicity of anticonvulsant drugs. I: Review of the literature. , 1984, American journal of medical genetics.

[70]  A. Primack Amelioration of cyclophosphamide-induced cystitis. , 1971, Journal of the National Cancer Institute.

[71]  D. Greenberg,et al.  Endothelins and the nervous system , 1992, Neurology.

[72]  A. T. Williams,et al.  Carbon Tetrachloride Hepatotoxicity: An Example of Free Radical-Mediated Injury , 1990, Seminars in liver disease.

[73]  M. Pirmohamed,et al.  Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. , 1991, British journal of clinical pharmacology.

[74]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[75]  M. Boyd,et al.  Superoxide and hydrogen peroxide production and NADPH oxidation stimulated by nitrofurantoin in lung microsomes: possible implications for toxicity. , 1979, Life sciences.

[76]  C. Day,et al.  Genetic predisposition to alcoholic liver disease. , 1992, Gut.

[77]  C. Goldsmith,et al.  Is enflurane hepatotoxic? , 1986, Anesthesia and analgesia.

[78]  J Kao,et al.  Cutaneous metabolism of xenobiotics. , 1990, Drug metabolism reviews.

[79]  F. Dreifuss,et al.  Valproic acid hepatic fatalities. , 1989, Neurology.

[80]  Fetal hydantoin syndrome. , 1975, Lancet.

[81]  R. Mason,et al.  Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. , 1991, Molecular pharmacology.

[82]  J. A. Page,et al.  Cardiotoxicity of adriamycin and related anthracyclines. , 1976, Cancer treatment reviews.

[83]  M. Rawlins Pathogenesis of adverse drug reactions , 1977 .

[84]  B. K. Park,et al.  An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system. , 1990, British journal of clinical pharmacology.

[85]  K. Chiba,et al.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.

[86]  H. Prentice,et al.  Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. , 1984, Annals of internal medicine.

[87]  A. Yunis,et al.  Drug-induced red cell dyscrasias. , 1989, Blood reviews.

[88]  A. Fantel,et al.  Xenobiotic biotransformation/bioactivation in organogenesis-stage conceptual tissues: implications for embryotoxicity and teratogenesis. , 1992, Drug metabolism reviews.

[89]  Spielberg Sp In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. , 1984 .

[90]  E. Jeffery Human Drug Metabolism: From Molecular Biology to Man , 1992 .

[91]  B. Levine Immunochemical Mechanisms Involved in Penicillin Hypersensitivity in Experimental Animals and in Human Beings , 1964, Federation proceedings.

[92]  D. Roden,et al.  Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. , 1980, The American journal of cardiology.

[93]  J. Hanson Teratogen update: fetal hydantoin effects. , 1986, Teratology.

[94]  D. Jerina,et al.  Arene oxides: a new aspect of drug metabolism. , 1974, Science.

[95]  M. Page,et al.  The mechanisms of reactions of .beta.-lactam antibiotics , 1984 .

[96]  G. Rodgers,et al.  Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations , 1988, American journal of hematology.

[97]  L. Goldsmith Physiology, biochemistry, and molecular biology of the skin , 1991 .

[98]  W. Evans,et al.  Age-related adriamycin cardiotoxicity in children. , 1978, Cancer treatment reports.

[99]  K. Benitz,et al.  Renal Toxicity of Tetracycline Degradation Products , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[100]  C. R. Spence,et al.  The incidence of bladder cancer after cyclophosphamide therapy. , 1979, The Journal of urology.

[101]  J. Neuberger Halothane and Hepatitis , 1990 .

[102]  J. Kao Estimating the Contribution by Skin to Systemic Metabolism , 1988, Annals of the New York Academy of Sciences.

[103]  R. Baldessarini,et al.  Clozapine. A novel antipsychotic agent. , 1991, The New England journal of medicine.

[104]  R. Day,et al.  Clinical pharmacology of non-steroidal anti-inflammatory drugs. , 1987, Pharmacology & therapeutics.

[105]  J. Groopman,et al.  Haematologic manifestations of the human immune deficiency virus (HIV) , 1987, British journal of haematology.

[106]  D. Jollow,et al.  Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. , 1988, The Journal of pharmacology and experimental therapeutics.

[107]  R. Branch,et al.  Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4. , 1992, Molecular pharmacology.

[108]  M. Juchau Bioactivation in chemical teratogenesis. , 1989, Annual review of pharmacology and toxicology.

[109]  S. Nelson Molecular Mechanisms of the Hepatotoxicity Caused by Acetaminophen , 1990, Seminars in liver disease.

[110]  P. Eyer,et al.  Formation and disposition of nitrosochloramphenicol in rat liver. , 1985, Biochemical pharmacology.

[111]  L. L. Smith,et al.  The relevance of pentose phosphate pathway stimulation in rat lung to the mechanism of paraquat toxicity. , 1976, Biochemical pharmacology.

[112]  D. Fine,et al.  Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro , 1983 .

[113]  C. Wolf,et al.  Evidence that the androgen receptor mediates sexual differentiation of mouse renal cytochrome P450 expression. , 1991, The Biochemical journal.

[114]  C. L. Ferguson,et al.  Torsades de pointes occurring in association with terfenadine use. , 1990, JAMA.

[115]  A. Pisciotta Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. , 1990, Blood reviews.

[116]  F. Muggia,et al.  Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529). , 1990, Pharmacology & therapeutics.

[117]  R. Stern,et al.  The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. , 1990 .

[118]  M. Cousins,et al.  Renal toxicity of anaesthetics: With specific references to the nephrotoxicity of methoxyflurane , 1973, Canadian Anaesthetists' Society journal.

[119]  R. Bevan,et al.  Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells. , 1991, Molecular pharmacology.

[120]  T. Baillie,et al.  Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[121]  I. Ifrim,et al.  Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. , 1977, Science.

[122]  G. Alexander,et al.  Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine , 1990, The Lancet.

[123]  J. Kehrer,et al.  Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity. , 1991, Cancer research.

[124]  H. Thurston,et al.  Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. , 1987, The Quarterly journal of medicine.

[125]  F. Dreifuss,et al.  Valproic acid hepatic fatalities , 1987, Neurology.

[126]  M. Boyd Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.

[127]  J. Groopman,et al.  Hematologic manifestations of the human immune deficiency virus (HIV). , 1988, Seminars in hematology.

[128]  A. Miller,et al.  Nitroso-chloramphenicol: possible mediator in chloramphenicol-induced aplastic anemia. , 1980, The Journal of laboratory and clinical medicine.

[129]  B. Kerr,et al.  INHIBITION OF EPOXIDE HYDROLASE BY ANTICONVULSANTS AND RISK OF TERATOGENICITY , 1989, The Lancet.

[130]  D. Pessayre,et al.  Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. , 1983, Biochemical pharmacology.

[131]  R. Hook,et al.  Pharmacokinetics and biotransformation studies of terfenadine in man. , 1982, Arzneimittel-Forschung.

[132]  M. Miller,et al.  Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[133]  O. Kofman Deprenyl: Protective vs. Symptomatic Effect , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[134]  M. Tirmenstein,et al.  Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. , 1989, The Journal of biological chemistry.

[135]  A. Forbes,et al.  Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. , 1991, BMJ.

[136]  J. Neuberger,et al.  Evidence for expression in human liver of halothane‐induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis , 1988, Hepatology.

[137]  J. Tredger,et al.  Long-Term Anticonvulsant Therapy Worsens Outcome in Paracetamol-Induced Fulminant Hepatic Failure , 1992, Human & experimental toxicology.

[138]  G. Bakris,et al.  Acute Interstitial Nephritis with Glomerulopathy Due to Nonsteroidal Anti‐Inflammatory Agents: A Review of Its Clinical Spectrum and Effects of Steroid Therapy , 1990, Journal of clinical pharmacology.

[139]  H. Satoh,et al.  Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis , 1988, Anesthesiology.

[140]  R. Blaese,et al.  Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[141]  J. Lieberman,et al.  Update on the clinical efficacy and side effects of clozapine. , 1991, Schizophrenia bulletin.

[142]  H. Sewell,et al.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. , 1988, British journal of clinical pharmacology.

[143]  J. Patel,et al.  Metabolism and pulmonary toxicity of cyclophosphamide. , 1990, Pharmacology & therapeutics.

[144]  J. Uetrecht Metabolism of drugs by activated leukocytes: implications for drug-induced lupus and other drug hypersensitivity reactions. , 1991, Advances in experimental medicine and biology.

[145]  P. Bk Metabolic Basis of Adverse Drug Reactions , 1986, Journal of the Royal College of Physicians of London.

[146]  P. G. Wells,et al.  Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. , 1992, Gastroenterology.

[147]  D. Pessayre,et al.  Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. , 1983, Biochemical pharmacology.

[148]  S. Chaplin Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. , 1986, Adverse drug reactions and acute poisoning reviews.

[149]  D. White,et al.  Bleomycin-induced pulmonary toxicity. , 1990, Clinics in chest medicine.

[150]  R. Balling,et al.  Oxidative and conjugative metabolism of diethylstilbestrol by rabbit preimplantation embryos. , 1985, Developmental Biology.

[151]  A. Salama,et al.  The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. , 1985, The New England journal of medicine.

[152]  S. Nelson,et al.  Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. , 1993, Biochemical pharmacology.

[153]  K. Ormstad,et al.  Renal transport and disposition of Na‐2‐mercaptoethane sulfonate disulfide (Dimesna) in the rat , 1982, FEBS letters.

[154]  G. Powis,et al.  Enzymatic and non-enzymatic reduction of N-acetyl-p-benzoquinone imine and some properties of the N-acetyl-p-benzosemiquinone imine radical. , 1984, Biochemical pharmacology.

[155]  D. Devine,et al.  Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. , 1992, The New England journal of medicine.

[156]  L. Benet,et al.  Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.

[157]  S. Spielberg,et al.  Acetaminophen toxicity in human lymphocytes in vitro. , 1980, The Journal of pharmacology and experimental therapeutics.

[158]  J. Doroshow,et al.  The effect of doxorubicin on hepatic and cardiac glutathione. , 1979, Research communications in chemical pathology and pharmacology.

[159]  R. Aur,et al.  Cyclophosphamide‐induced hemorrhagic cystitis in children with leukemia , 1975, Cancer.

[160]  Anthony E. Lang,et al.  Effect of deprenyl on the progression of disability in early Parkinson's disease. , 1989, The New England journal of medicine.

[161]  B. Habibi,et al.  NOMIFENSINE-INDUCED IMMUNE HÆMOLYTIC ANÆMIA AND IMPAIRED RENAL FUNCTION , 1979, The Lancet.

[162]  M. H. Gault,et al.  Toxic nephropathy after low-dose methoxyflurane anesthesia: drug interaction with secobarbital? , 1976, Canadian Medical Association journal.

[163]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[164]  S. Spielberg,et al.  Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. , 1990, Molecular pharmacology.

[165]  B. Longley,et al.  Immunology and the Skin Current Concepts , 1988, Annals of the New York Academy of Sciences.

[166]  C. V. Smith,et al.  Alkylation of the liver plasma membrane and inhibition of the Ca2+ ATPase by acetaminophen. , 1988, Biochemical pharmacology.

[167]  L. Benet,et al.  Irreversible binding of zomepirac to plasma protein in vitro and in vivo. , 1986, The Journal of clinical investigation.

[168]  H. Mukhtar,et al.  Cutaneous cytochrome P-450. , 1989, Drug metabolism reviews.

[169]  J. Mason,et al.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[170]  R D Olson,et al.  Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. , 1980, The Journal of pharmacology and experimental therapeutics.

[171]  P. Carrupt,et al.  The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism. , 1990, Drug metabolism reviews.

[172]  E. Andermann,et al.  GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTS , 1985, The Lancet.

[173]  P. Loiseau,et al.  Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: In vitro/in vivo correlation , 1989, Clinical pharmacology and therapeutics.

[174]  C. Dollery,et al.  HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY , 1980, The Lancet.

[175]  A. Breckenridge,et al.  Inhibition of Dapsone‐induced Methaemoglobinaemia in the Rat Isolated Perfused Liver , 1990, The Journal of pharmacy and pharmacology.

[176]  J. Bauer,et al.  Immediate rise in intracellular calcium and glycogen phosphorylase a activities upon acetaminophen covalent binding leading to hepatotoxicity in mice. , 1988, Toxicology.

[177]  D. Davies,et al.  Textbook of Adverse Drug Reactions , 1992, Annals of Internal Medicine.

[178]  R. Roman,et al.  Renal tubular site of action of fluoride in Fischer 344 rats. , 1977, Anesthesiology.

[179]  M. Pirmohamed,et al.  An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. , 1992, Biochemical pharmacology.

[180]  S. Snyder,et al.  II. Neuromelanin: A role in MPTP-induced neurotoxicity , 1987 .

[181]  E Scowen,et al.  Committee on Safety of Medicines. , 1978, British journal of anaesthesia.

[182]  N. Kitteringham,et al.  Drug disposition and drug hypersensitivity. , 1987, Biochemical pharmacology.

[183]  A. Benson,et al.  Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine. , 1992, Biochemical pharmacology.

[184]  U. Christen,et al.  Mechanisms of halothane toxicity: novel insights. , 1993, Pharmacology & therapeutics.

[185]  D. Morin,et al.  Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. , 1992, The Journal of pharmacology and experimental therapeutics.

[186]  B. Brodie,et al.  THE FATE OF ACETOPHENETIDIN (PHENACETIN) IN MAN AND METHODS FOR THE ESTIMATION OF ACETOPHENETIDIN AND ITS METABOLITES IN BIOLOGICAL MATERIAL , 1949 .

[187]  J. Uetrecht The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. , 1992, Drug metabolism reviews.

[188]  F. V. van Pelt,et al.  Immunohistochemical detection of cytochrome P450 isoenzymes in cultured human epidermal cells. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[189]  D. Wortham,et al.  The effect of fluconazole on the steady‐state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans , 1993, Clinical pharmacology and therapeutics.

[190]  T. Myers,et al.  Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. , 1993, Chemical research in toxicology.

[191]  J. Langston,et al.  MPTP and parkinson's disease , 1985, Trends in Neurosciences.

[192]  M. Boyd,et al.  Metabolic activation of nitrofurantoin--possible implications for carcinogenesis. , 1979, Biochemical pharmacology.

[193]  A. Mclean Why do patients still die from paracetamol poisoning? , 1986, British medical journal.

[194]  R. Lewin Trail of ironies to Parkinson's disease. , 1984, Science.

[195]  Parker Cw IMMUNOCHEMICAL MECHANISMS IN PENICILLIN ALLERGY. , 1965 .

[196]  J. de Jersey,et al.  Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects. , 1990, Alcohol and alcoholism.

[197]  L. L. Smith Mechanism of Paraquat Toxicity in Lung and its Relevance to Treatment , 1987, Human toxicology.

[198]  M. R. Boyd,et al.  Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.

[199]  N. Adkinson,et al.  Immediate hypersensitivity reactions to penicillin and related antibiotics , 1988, Clinical allergy.

[200]  Harman Aw The effectiveness of antioxidants in reducing paracetamol-induced damage subsequent to paracetamol activation. , 1985 .

[201]  L. Benet,et al.  Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[202]  R. Martino,et al.  Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[203]  A. Pablos-Mendez,et al.  Clinical Features and Management of Severe Dermatological Reactions to Drugs , 1990, Drug safety.

[204]  L. Pohl Drug-Induced Allergic Hepatitis , 1990, Seminars in liver disease.

[205]  J. Unadkat,et al.  Adverse reactions to co-trimoxazole in HIV infection , 1991, The Lancet.

[206]  T. Woolf,et al.  Basic Concepts in Drug Metabolism: Part II , 1987, Journal of clinical pharmacology.

[207]  F. Guengerich Metabolic activation of carcinogens. , 1992, Pharmacology & therapeutics.

[208]  S. Snyder,et al.  Characterization of the Binding of N‐Methyl‐4‐Phenylpyridine, the Toxic Metabolite of the Parkinsonian Neurotoxin N‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine, to Neuromelanin , 1987, Journal of Neurochemistry.

[209]  P. Gell,et al.  Clinical aspects of immunology , 1968 .

[210]  J. Neuberger,et al.  Halothane hepatitis: a model of immune mediated drug hepatotoxicity. , 1987, Clinical science.

[211]  M. Droller,et al.  Prevention of cyclophosphamide-induced hemorrhagic cystitis. , 1982, Urology.

[212]  J. Trudell,et al.  Methoxyflurane Metabolism and Renal Dysfunction: Clinical Correlation in Man , 1971, Anesthesiology.

[213]  D. Lindhout Pharmacogenetics and drug interactions: role in antiepileptic-drug-induced teratogenesis. , 1992, Neurology.

[214]  J. Aronson,et al.  Oxford Textbook of Clinical Pharmacology and Drug Therapy , 1985 .

[215]  J. Jimenez,et al.  Aerobic nitroreduction of dehydrochloramphenicol by bone marrow. , 1988, Toxicology and applied pharmacology.

[216]  W. Nicklas,et al.  Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium , 1986, Journal of neurochemistry.

[217]  H. Satoh,et al.  Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis. , 1988 .

[218]  T. Baillie,et al.  Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid. , 1987, Science.

[219]  M. Rieder,et al.  Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites. , 1989, Annals of internal medicine.

[220]  Yunis Aa Chloramphenicol toxicity: 25 years of research. , 1989 .

[221]  C. M. Leevy,et al.  Lymphocyte transformation and alcoholic liver injury. , 1972, Gastroenterology.

[222]  G. Gordon,et al.  Predisposition to phenytoin hepatotoxicity assessed in vitro. , 1981, The New England journal of medicine.

[223]  W. Johnson,et al.  Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. , 1971, The New England journal of medicine.

[224]  C. Lieber,et al.  Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. , 1989, Archives of biochemistry and biophysics.

[225]  P. Moldéus,et al.  Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. , 1985, Molecular pharmacology.

[226]  H. Satoh,et al.  Neoantigens associated with halothane hepatitis. , 1989, Drug metabolism reviews.

[227]  A. Breckenridge,et al.  The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. , 1990, British journal of clinical pharmacology.

[228]  S. Snyder,et al.  Evidence for neuromelanin involvement in MPTP-induced neurotoxicity , 1987, Nature.

[229]  S. Nelson,et al.  Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[230]  C. Lieber Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. , 1988, The New England journal of medicine.

[231]  R. Zetterman Autoimmunity and alcoholic liver disease. , 1990, The American journal of medicine.

[232]  M. Pirmohamed,et al.  Lack of interaction between sulphasalazine and cimetidine in patients with rheumatoid arthritis. , 1993, British journal of rheumatology.

[233]  B. Lauterburg,et al.  Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. , 1988, Gut.

[234]  J. Critchley,et al.  Acute haemolysis and renal failure after nomifensine overdosage. , 1980, British medical journal.

[235]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[236]  N. Abraham,et al.  Role of heme metabolism in AZT‐induced bone marrow toxicity , 1990, American journal of hematology.

[237]  J. K. Hurst,et al.  Leukocytic oxygen activation and microbicidal oxidative toxins. , 1989, Critical reviews in biochemistry and molecular biology.

[238]  G. Gordon,et al.  Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism. , 1981, The Journal of clinical investigation.

[239]  M. Pirmohamed,et al.  An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. , 1993, Biochemical pharmacology.

[240]  R. Kauffman,et al.  Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. , 1984, The Journal of pediatrics.

[241]  B. Stricker,et al.  Drug-induced hepatic injury. A comprehensive survey of the literature on adverse drug reactions up to January 1985. , 1985 .

[242]  R. Olson,et al.  Doxorubicin cardiotoxicity: analysis of prevailing hypotheses , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[243]  Steven D. Cohen,et al.  Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. , 1988, Toxicology and applied pharmacology.

[244]  Y. Israel,et al.  Antibodies against acetaldehyde‐modified protein epitopes in human alcoholics , 1987, Hepatology.

[245]  A. Breckenridge,et al.  Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. , 1989, British journal of clinical pharmacology.

[246]  M. Pirmohamed,et al.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. , 1992, British journal of clinical pharmacology.

[247]  T. Quinn,et al.  More on routine HIV screening. , 1993, The New England journal of medicine.

[248]  D. V. Vander Jagt,et al.  Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. , 1994, Molecular pharmacology.

[249]  D. Morin,et al.  Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung. , 1991, The Journal of pharmacology and experimental therapeutics.

[250]  J A Lieberman,et al.  A Report of Clozapine-Induced Agranulocytosis in the United States , 1992, Drug safety.

[251]  M. Pirmohamed,et al.  The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. , 1992, Biochemical pharmacology.

[252]  M. Tirmenstein,et al.  Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. , 1990, The Journal of biological chemistry.

[253]  P. Watkins Role of Cytochromes P45O in Drug Metabolism and Hepatotoxicity , 1990, Seminars in liver disease.

[254]  D. Drayer,et al.  Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. , 1979, The New England journal of medicine.

[255]  L. Klassen,et al.  Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. , 1992, Gastroenterology.

[256]  M. Goto,et al.  Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors , 1988, Epilepsia.

[257]  B. Brodie,et al.  ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. III. CYTOCHROME P-450-MEDIATED COVALENT BINDING IN VITRO , 1973 .